Respiratory muscle training (RMT) in late-onset Pompe disease (LOPD): Effects of training and detraining

Molecular Genetics and Metabolism - Tập 117 - Trang 120-128 - 2016
Harrison N. Jones1, Kelly D. Crisp2, Randall R. Robey3, Laura E. Case4, Richard M. Kravitz5, Priya S. Kishnani6
1Department of Surgery, Division of Head and Neck Surgery & Communication Sciences, Duke University, Durham, NC, USA
2Department of Speech Pathology & Audiology, Duke University, Durham, NC, USA
3Communication Disorders, University of Virginia, Charlottesville, VA, USA
4Physical Therapy Division, Duke University, Durham, NC, USA
5Division of Pediatric Pulmonary and Sleep Medicine, Duke University, Durham, NC, USA
6Department of Pediatrics, Division of Medical Genetics, Duke University, Durham, NC, USA

Tài liệu tham khảo

Kishnani, 2006, Pompe disease diagnosis and management guideline, Genet. Med., 8, 267, 10.1097/01.gim.0000218152.87434.f3 Kroos, 2012, The genotype-phenotype correlation in Pompe disease, Am. J. Med. Genet. C: Semin. Med. Genet., 160, 59, 10.1002/ajmg.c.31318 Dubrovsky, 2011, Expanding the phenotype of late-onset Pompe disease: tongue weakness: a new clinical observation, Muscle Nerve, 44, 897, 10.1002/mus.22202 Jones, 2015, Quantitative assessment of lingual strength in late-onset Pompe disease, Muscle Nerve, 51, 731, 10.1002/mus.24523 Horvath, 2015, Correlation between quantitative whole-body muscle magnetic resonance imaging and clinical muscle weakness in Pompe disease, Muscle Nerve, 51, 722, 10.1002/mus.24437 Yanovitch, 2010, Clinical and histologic ocular findings in Pompe disease, J. Pediatr. Opthalmol. Strabismus, 47, 34, 10.3928/01913913-20100106-08 Yanovitch, 2010, Improvement of bilateral ptosis on higher dose enzyme replacement therapy in Pompe disease, J. Neuroopthalmol., 30, 165, 10.1097/WNO.0b013e3181ce162a Bernstein, 2010, Pompe disease: dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients., Mol. Genet. Metab., 101, 130, 10.1016/j.ymgme.2010.06.003 Muller-Felber, 2007, Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients, Neuromuscul. Disord., 17, 698, 10.1016/j.nmd.2007.06.002 Prigent, 2012, Supine volume drop and diaphragmatic function in adults with Pompe disease, Eur. Respir. J., 39, 1545, 10.1183/09031936.00169011 Boentert, 2015, Sleep-related symptoms and sleep-disordered breathing in adult Pompe disease, Eur. J. Neurol., 22, 369, 10.1111/ene.12582 Jung, 2014, Comparison of muscle activities using a pressure biofeedback unit during abdominal muscle training performed by normal adults in the standing and supine positions, J. Phys. Ther. Sci., 26, 191, 10.1589/jpts.26.191 Lee, 2013, Effects of abdominal hollowing during stair climbing on the activations of local trunk stabilizing muscles: a cross-sectional study, Ann. Rehabil. Med., 37, 804, 10.5535/arm.2013.37.6.804 Case, 2006, Physical therapy management of Pompe disease, Genet. Med., 8, 318, 10.1097/01.gim.0000217789.14470.c5 van der Ploeg, 2010, A randomized study of alglucosidase alfa in late-onset Pompe's disease, N. Engl. J. Med., 362, 1396, 10.1056/NEJMoa0909859 Toscano, 2013, Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review, J. Neurol., 260, 951, 10.1007/s00415-012-6636-x Regnery, 2012, 36months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy, J. Inherit. Metab. Dis., 35, 837, 10.1007/s10545-012-9451-8 Battaglia, 2009, Rationale of the combined use of inspiratory and expiratory devices in improving maximal inspiratory pressure and maximal expiratory pressure of patients with chronic obstructive pulmonary disease, Arch. Phys. Med. Rehabil., 90, 913, 10.1016/j.apmr.2008.12.019 Forbes, 2011, The effect of inspiratory and expiratory respiratory muscle training in rowers, Res. Sports Med., 19, 217, 10.1080/15438627.2011.608033 Jones, 2011, Increased inspiratory and expiratory muscle strength following respiratory muscle strength training (RMST) in two patients with late-onset Pompe disease, Mol. Genet. Metab., 104, 417, 10.1016/j.ymgme.2011.05.006 Lotters, 2002, Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis, Eur. Respir. J., 20, 570, 10.1183/09031936.02.00237402 Weiner, 1998, Respiratory muscle training in patients with moderate to severe myasthenia gravis, Can. J. Neurol. Sci., 25, 236, 10.1017/S0317167100034077 Jones, 2014, Effects of respiratory muscle training (RMT) in children with infantile-onset Pompe disease and respiratory muscle weakness, J. Pediatr. Rehabil. Med., 7, 255, 10.3233/PRM-140294 Cupler, 2012, Disease ACCoL-oP: consensus treatment recommendations for late-onset Pompe disease, Muscle Nerve, 45, 319, 10.1002/mus.22329 Nilsson, 2012, Aerobic training as an adjunctive therapy to enzyme replacement in Pompe disease, Mol. Genet. Metab., 107, 469, 10.1016/j.ymgme.2012.09.010 Favejee, 2014, Exercise training in adults with pompe disease: the effects on pain, fatigue, and functioning, Arch. Phys. Med. Rehabil. Terzis, 2011, Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy, Mol. Genet. Metab., 104, 279, 10.1016/j.ymgme.2011.05.013 van den Berg, 2015, Safety and efficacy of exercise training in adults with Pompe disease: evaluation of endurance, muscle strength, and core stability before and after a 12week training program, Orphanet J. Rare Dis., 10, 10.1186/s13023-015-0303-0 Backman, 1997, Single-subject research in rehabilitation: a review of studies using AB, withdrawal, multiple baseline, and alternating treatments designs, Arch. Phys. Med. Rehabil., 78, 1145, 10.1016/S0003-9993(97)90142-8 Janosky, 2009 Robey, 1999, Single-subject versus randomized group design, ASHA, 41, 14 Busk, 1992, Meta-analysis for single-case research McDonald, 2013, The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study, Muscle Nerve, 48, 357, 10.1002/mus.23905 American Thoracic Society/European Respiratory S, 2002, ATS/ERS statement on respiratory muscle testing, Am. J. Respir. Crit. Care Med., 166, 518, 10.1164/rccm.166.4.518 Evans, 2009, The assessment of maximal respiratory mouth pressures in adults, Respir. Care, 54, 1348 2002, ATS statement: guidelines for the six-minute walk test, Am. J. Respir. Crit. Care Med., 166, 111, 10.1164/ajrccm.166.1.at1102 Koessler, 2001, 2years' experience with inspiratory muscle training in patients with neuromuscular disorders, Chest, 120, 765, 10.1378/chest.120.3.765 Wanke, 1994, Inspiratory muscle training in patients with Duchenne muscular dystrophy, Chest, 105, 475, 10.1378/chest.105.2.475 Gozal, 1999, Respiratory muscle training in neuromuscular disease: long-term effects on strength and load perception, Med. Sci. Sports Exerc., 31, 1522, 10.1097/00005768-199911000-00005 McCool, 1995, Inspiratory muscle training in the patient with neuromuscular disease, Phys. Ther., 75, 1006, 10.1093/ptj/75.11.1006 Alejaldre, 2012, Trunk muscle involvement in late-onset Pompe disease: study of thirty patients, Neuromuscul. Disord., 22, S148, 10.1016/j.nmd.2012.05.011 Black, 1969, Maximal respiratory pressures: normal values and relationship to age and sex, Am. Rev. Respir. Dis., 99, 696 Kaptchuk, 2006, Sham device v inert pill: randomised controlled trial of two placebo treatments, BMJ, 332, 391, 10.1136/bmj.38726.603310.55